Free shipping on all orders over $ 500

 About 1 result found for searched term "Bivatuzumab" (0.135 seconds)

Cat.No.  Name Target
M24950 Bivatuzumab Others
BIWA 4 Anti-CD44 Recombinant Antibody
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.